Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10825637 | 0.92 | MEN1 (0.46) | MEN1ALDH1A1TP53CYP3A4MAPT | |
| SCHEMBL28398409 | 0.92 | MEN1 (0.46) | MEN1ALDH1A1TP53CYP3A4MAPT | |
| SCHEMBL5674844 | 0.90 | MEN1 (0.57) | MEN1ALDH1A1TP53CYP3A4MAPT | |
| SCHEMBL19021269 | 0.86 | MEN1 (0.50) | MEN1ALDH1A1TP53CYP3A4MAPT | |
| SCHEMBL5675101 | 0.86 | MEN1 (0.58) | MEN1ALDH1A1TP53CYP3A4MAPT | |
| SCHEMBL6446552 | 0.84 | MEN1 (0.43) | MEN1ALDH1A1TP53CYP3A4MAPT | |
| SCHEMBL5673651 | 0.84 | ALDH1A1 (0.43) | MEN1ALDH1A1TP53CYP3A4MAPT | |
| SCHEMBL28712246 | 0.84 | MEN1 (0.57) | MEN1ALDH1A1TP53CYP3A4MAPT | |
| SCHEMBL5674848 | 0.84 | MEN1 (0.50) | MEN1ALDH1A1TP53CYP3A4MAPT | |
| SCHEMBL1793668 | 0.83 | MEN1 (0.48) | MEN1ALDH1A1TP53CYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7217827-B2 | Halogen-containing aromatic compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2007-05-15 | — | — | US | disclosed |
| US-7132561-B2 | Process for producing fluorinated dicyanobenzene | SHOWA DENKO K.K. (JP) | 2006-11-07 | — | — | US | disclosed |
| EP-1324977-B1 | PROCESS FOR PRODUCING FLUORINATED DICYANOBENZENE | SHOWA DENKO KK (JP) | 2006-02-01 | — | — | EP | disclosed |
| CN-1219775-C | Halogen contained aromatic compound | NIPPON CATALYTIC CHEM IND (JP) | 2005-09-21 | — | — | CN | disclosed |
| US-6916959-B2 | Halogen-containing aromatic compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2005-07-12 | — | — | US | disclosed |
| US-20050090691-A1 | Halogen-containing aromatic compound | NIPPON SHOKUBAI CO., LTD., A JAPAN CORPORATION | 2005-04-28 | — | — | US | disclosed |
| EP-1256564-B1 | Halogen-containing aromatic compound | NIPPON CATALYTIC CHEM IND (JP) | 2004-07-28 | — | — | EP | disclosed |
| US-20040030173-A1 | Process for producing fluorinated dicyanobenzene | SHOWA DENKO K.K. (JP) | 2004-02-12 | — | — | US | disclosed |
| EP-1324977-A2 | PROCESS FOR PRODUCING FLUORINATED DICYANOBENZENE | Showa Denko K.K. (JP) | 2003-07-09 | — | — | EP | disclosed |
| US-20030018204-A1 | Halogen-containing aromatic compound | NIPPON SHOKUBAI CO., LTD. (JP) | 2003-01-23 | — | — | US | disclosed |
| CN-1385427-A | Halogen contained aromatic compound | NIPPON CATALYTIC CHEM IND (JP) | 2002-12-18 | — | — | CN | disclosed |
| EP-1256564-A1 | Halogen-containing aromatic compound | Nippon Shokubai Co., Ltd. (JP) | 2002-11-13 | — | — | EP | disclosed |
| WO-2002028822-A2 | PROCESS FOR PRODUCING FLUORINATED DICYANOBENZENE | SHOWA DENKO K.K. (JP) | 2002-04-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040030173-A1 | Process for producing fluorinated dicyanobenzene | FLNB, TDO2, HRH4 | MEN1 2618/4885ALDH1A1 3567/4885TP53 454/4885 |
| US-20050090691-A1 | Halogen-containing aromatic compound | TYR, AFF4, DDT | MEN1 492/4885ALDH1A1 1243/4885TP53 1531/4885 |
| US-20030018204-A1 | Halogen-containing aromatic compound | TYR, AFF4, DDT | MEN1 492/4885ALDH1A1 1243/4885TP53 1531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.